Investors
HTG Molecular is a privately held corporation. Novo A/SNovo A/S as venture capital provider is committed to support sustainable partnerships through the advancement of life sciences. The aspiration is to bring together the best of both worlds: industry insight and network from our pharma/biotech inheritance combined with a venture capital mindset that focuses on results and value creation. Merck Capital VenturesMerck Capital Ventures is a subsidiary of Merck & Co., Inc. founded in November 2000. Merck Capital Ventures (MCV) actively invests in emerging businesses with interesting technology in areas related to the commercialization, distribution and delivery of pharmaceuticals and related healthcare services. The focus of MCV is to invest in technologies that accelerate innovation related to the pharmaceutical business and other sectors of health care delivery. Solstice CapitalSolstice Capital seeks superior venture capital returns for its limited partners through investments in seed- and early-stage companies in the alternative energy, education, environmental, life sciences and information technology industries. Solstice’s seasoned management team with over 90 years of experience in both venture investing and operations in high-growth companies and emphasis on positive impact investing are its unique assets and distinct advantages. SR-oneSR-one is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. It establishes and nourishes investments in a portfolio of cutting edge, early-stage companies based on differentiation and innovation. Valley VenturesValley Ventures is an institutionally-funded venture capital partnership. The general partner is a team of experienced venture capitalists and managers dedicated to the achievement of superior investment returns by investing in and assisting emerging growth companies in the greater Southwest U.S. In addition to providing capital to growing companies, Valley Ventures assists management in strategic planning, management development, gaining access to key industry experts and advising on capital formation events. Fletcher Spaght VenturesFletcher Spaght Ventures invests in healthcare, life science and high technology companies with growth potential. Fletcher Spaght Ventures leverages the strategy consulting arm of the firm, Fletcher Spaght Inc., to assess the potential for each investment opportunity. Post investment, the Fletcher Spaght team contributes industry knowledge, general strategic and analytical expertise to assist portfolio companies to enhance value and achieve their potential. |